Reltio
MAY 16, 2023
These platforms help manage data quality challenges in real-time ensuring that business users have the accurate, up-to-date information they need for sound decision making. In this blog post, we explore the significance of data quality in the pharmaceutical industry and explain how a modern MDM platform serves to address these challenges.
The Guardian Data Protection
JUNE 12, 2021
It is easy to mistrust big data collection, but for health the benefits are well established Kenan Malik entered an argument with many facets (“ Tell me how you’ll use my medical data. They are a major resource to ensure that pharmaceuticals are used safely and effectively. Only then might I sign up ”, Comment).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Data Matters
JUNE 9, 2021
NHS Digital (the national custodian for health and care data in England) in May 2021, announced a new data sharing initiative called the General Practice Data for Planning and Research (GPDPR) service. The Notice further states that the data will never be shared with marketing or insurance companies.
Security Affairs
DECEMBER 10, 2020
The threat actors used lures consisted of documents about Sinopharm International Corporation, a pharmaceutical company involved in the development of a COVID-19 vaccine and that is currently going through phase three clinical trials. The malware connects to the C2 through HTTP POST requests.
IBM Big Data Hub
AUGUST 7, 2023
Despite advancements in the pharmaceutical industry and biomedical research, delivering drugs to market is still a complex process with tremendous opportunity for improvement. The ability to seize these advantages is one way that pharmaceutical companies may be able to gain sizable competitive edge.
IBM Big Data Hub
AUGUST 11, 2023
Data analytics and reporting: The MES software should provide comprehensive analytics and reporting capabilities, allowing you to track and analyze KPIs, production trends and efficiency metrics. pharmaceuticals, aerospace, etc.), Compliance and security: For industries with strict regulatory requirements (e.g.,
DLA Piper Privacy Matters
APRIL 8, 2019
This fragmentation has, unsurprisingly, lead to a heavy administrative burden for the secondary users of social and health care data by parallel and slow licence procedures with various authorities.
Expert insights. Personalized for you.
52 
Let's personalize your content